both using the Amplatzer PFO occluder as the closure device. These trials continue to include only migraine patients refractory to preventive therapy, but they need to have more headache-free days ...

This risk may be reduced by blood-thinning medication. For patients with AFib who are unable to take blood-thinning medication long term, physicians may opt for occlusion (or closure) of the LAA ...